Form D · Biotechnology
Brainstage Inc
Carnegie, PA · CIK 0001408264
Offering snapshot reported Mar 26, 2015 · SEC filing
- Reported sold
- $2.2M Offering amount: $2.5M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 3, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 26, 2015 | Initial | $2,200,000 | No comparison | 22 | SEC filing |
| Jan 7, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 27, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-236679
Source: Form D, filed Mar 26, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony A. Florence | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
215 Park Road Suite 725
Carnegie, PA, 15206
Carnegie, PA, 15206